C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
暂无分享,去创建一个
C. Masters | P. Crouch | Qiao-Xin Li | M. Hasegawa | M. Bogoyevitch | Anthony R White | K. Kanninen | T. Nonaka | K. Price | A. Caragounis | Anthony R. White | Dominic C. H. Ng | Sarah J. Parker | L. Vella | J. Meyerowitz | J. R. Liddell | A. White | Jeffrey R. Liddell | Aphrodite Caragounis
[1] I. Ferrer,et al. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS , 2011, Acta Neuropathologica.
[2] E. Huey,et al. FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.
[3] G. Rouleau,et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. , 2011, Human molecular genetics.
[4] J. Julien,et al. ALS pathogenesis: Recent insights from genetics and mouse models , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] J. Vickers,et al. Neuron–glia interactions underlie ALS-like axonal cytoskeletal pathology , 2011, Neurobiology of Aging.
[6] D. Ito,et al. Nuclear transport impairment of amyotrophic lateral sclerosis‐linked mutations in FUS/TLS , 2011, Annals of neurology.
[7] Daniel R. Dries,et al. TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor , 2010, Molecular and Cellular Biology.
[8] L. Petrucelli,et al. Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue , 2010, PloS one.
[9] I. Mackenzie,et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.
[10] I. Blair,et al. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. , 2010, The international journal of biochemistry & cell biology.
[11] I. Mackenzie,et al. ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.
[12] T. Hortobágyi,et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. , 2010, Brain : a journal of neurology.
[13] C. Masters,et al. Zinc induces depletion and aggregation of endogenous TDP-43. , 2010, Free radical biology & medicine.
[14] R. Flavell,et al. JNK3 Mediates Paraquat- and Rotenone-Induced Dopaminergic Neuron Death , 2010, Journal of neuropathology and experimental neurology.
[15] John Q. Trojanowski,et al. TAR DNA-binding protein 43 in neurodegenerative disease , 2010, Nature Reviews Neurology.
[16] E. Choi,et al. Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.
[17] P. Shaw,et al. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.
[18] M. Bogoyevitch,et al. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. , 2010, Biochimica et biophysica acta.
[19] R. Chitta,et al. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. , 2010, Journal of proteome research.
[20] A. Bhattacharyya,et al. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 , 2010, International journal of cancer.
[21] A. Aronheim,et al. A Novel c-Jun N-terminal Kinase (JNK)-binding Protein WDR62 Is Recruited to Stress Granules and Mediates a Nonclassical JNK Activation , 2010, Molecular biology of the cell.
[22] R. Parker,et al. Eukaryotic stress granules: the ins and outs of translation. , 2009, Molecular cell.
[23] H. Koh,et al. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. , 2009, Toxicology letters.
[24] M. Strong,et al. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) , 2009, Brain Research.
[25] M. Iwashima,et al. hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation. , 2009, International immunology.
[26] D. Ito,et al. Characterization of Alternative Isoforms and Inclusion Body of the TAR DNA-binding Protein-43* , 2009, The Journal of Biological Chemistry.
[27] E. Buratti,et al. TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.
[28] R. Kalb,et al. A Switch in Retrograde Signaling from Survival to Stress in Rapid-Onset Neurodegeneration , 2009, The Journal of Neuroscience.
[29] E. Kremmer,et al. Proteolytic processing of TAR DNA binding protein‐43 by caspases produces C‐terminal fragments with disease defining properties independent of progranulin , 2009, Journal of neurochemistry.
[30] H. Akiyama,et al. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43 , 2009, Alzheimer's & Dementia.
[31] N. Shimada,et al. p38 MAP Kinase-dependent regulation of the expression level and subcellular distribution of heterogeneous nuclear ribonucleoprotein A1 and its involvement in cellular senescence in normal human fibroblasts , 2009, RNA biology.
[32] A. D’Ambrogio,et al. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo , 2009, Nucleic acids research.
[33] L. Petrucelli,et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.
[34] P. Leigh,et al. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport , 2009, Neuroscience Letters.
[35] J. Trojanowski,et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies* , 2009, Journal of Biological Chemistry.
[36] H. Akiyama,et al. Phosphorylated and ubiquitinated TDP‐43 pathological inclusions in ALS and FTLD‐U are recapitulated in SH‐SY5Y cells , 2009, FEBS letters.
[37] M. Strong,et al. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury , 2009, Brain Research.
[38] Maurizio Pellecchia,et al. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site , 2008, Proceedings of the National Academy of Sciences.
[39] C. L. Costantino,et al. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells , 2008, Cancer biology & therapy.
[40] A. Isaacs,et al. TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander , 2008, Mammalian Genome.
[41] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[42] P. Shaw,et al. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. , 2006, Biochimica et biophysica acta.
[43] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[44] S. Guil,et al. hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response , 2006, Molecular and Cellular Biology.
[45] J. Julien,et al. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS , 2006, Molecular and Cellular Neuroscience.
[46] E. Buratti,et al. TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail , 2005, Journal of Biological Chemistry.
[47] Rodolfo Marquez,et al. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. , 2005, Immunity.
[48] G. Perry,et al. Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway , 2003, Redox report : communications in free radical research.
[49] B. Ghetti,et al. Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis , 2001, Journal of neuropathology and experimental neurology.
[50] A L Burlingame,et al. Identification of New JNK Substrate Using ATP Pocket Mutant JNK and a Corresponding ATP Analogue* , 2001, The Journal of Biological Chemistry.
[51] Kavita Shah,et al. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation , 2001, Nature Cell Biology.
[52] D. Troost,et al. c‐Jun, JNK/SAPK Kinase and Transcription Factor NF-κB Are Selectively Activated in Astrocytes, but not Motor Neurons, in Amyotrophic Lateral Sclerosis , 1997, Journal of neuropathology and experimental neurology.
[53] S. Finkbeiner,et al. Pathogenic TARDBP Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Disease-Associated Pathways , 2010, Reviews in the neurosciences.